![Steve Daly](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Steve Daly currently works as a Chief Operating Officer at Abvance Therapeutics, Inc.
Postes actifs de Steve Daly
Sociétés | Poste | Début |
---|---|---|
Abvance Therapeutics, Inc.
![]() Abvance Therapeutics, Inc. BiotechnologyHealth Technology Abvance Therapeutics, Inc. is a pharmaceutical company that aims to improve diabetes control and reduce the risk of hypoglycemia. The company is based in Reno, NV. The company's Abv100 platform is designed to replace rapid acting insulin and can be used by any patient type, including those with type 1 and type 2 diabetes who use injections or pumps. The platform protects against hypoglycemia, allowing for safer use of insulin and better control of diabetes, which can lead to improved long-term health outcomes. The company was founded in 2016 by Alan Cherrington, David Maggs, and Soumitra Ghosh. David Maggs has been the CEO since 2016. | Directeur des opérations | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Abvance Therapeutics, Inc.
![]() Abvance Therapeutics, Inc. BiotechnologyHealth Technology Abvance Therapeutics, Inc. is a pharmaceutical company that aims to improve diabetes control and reduce the risk of hypoglycemia. The company is based in Reno, NV. The company's Abv100 platform is designed to replace rapid acting insulin and can be used by any patient type, including those with type 1 and type 2 diabetes who use injections or pumps. The platform protects against hypoglycemia, allowing for safer use of insulin and better control of diabetes, which can lead to improved long-term health outcomes. The company was founded in 2016 by Alan Cherrington, David Maggs, and Soumitra Ghosh. David Maggs has been the CEO since 2016. | Health Technology |